Press Release: Variations in how biosimilar products are named may affect the willingness of some pharmacists to substitute an interchangeable biologic for its branded reference product, according to a survey study published in this month’s Journal of Managed Care & Specialty Pharmacy (JMCP).
AMCP CEO Blog: It was only ten years ago when biosimilars were so new that the New York Times described them as “so-called.” As late as five years ago newspapers put quotation marks around the term, as in “biosimilars.”
Press Release: The Academy of Managed Care Pharmacy is proud to announce the launch of the Biosimilars Resource Center (BRC), an unbiased, policy-neutral repository of educational resources and information on biosimilars for pharmacists, physicians, nurses and other health care providers.
Partnership Forum: Industry leaders gathered June 10-11, 2015 to address the current readiness of MCOs to optimize biosimilars and identify gaps and resources needed.
AMCP webinar that addresses the science behind data consortiums, and also looks at why AMCP is engaging data consortiums, managed care specialty drug experts, researchers and industry to help launch the AMCP Biosimilars Collective Intelligence Consortium before the first biosimilars hit the market.